（來源：論文截圖）

發布期刊：Frontiers in Cell and Developmental Biology

作者：Xi Zhao1,2?, Guolin Miao1,3?, Lijun Zhang1?, Yuke Zhang1, Huanhuan Zhao1, Zhelong Xu1,Beibei Wang1* and Lijun Zhang1*

作者單位：天津醫科大學病理生理學

DOI ：doi.org/10.3389/fcell.2022.879023

引用試劑：HAKATA  PBS緩沖液

影響因子：6.08

論文簡述

Infection is closely related to atherosclerosis, which is a major pathological basis for cardiovascular diseases. Vascular smooth muscle cell (VSMC) migration is an important trigger in development of atherosclerosis that is associated with Chlamydia pneumoniae (C. pneumoniae) infection. However, the mechanism of VSMC migration remains unclear, and whether antioxidant could be a therapeutic target for C. pneumoniae infection-induced atherosclerosis also remains unknown. The results showed that C. pneumoniae infection mainly impaired mitochondrial function and increased the level of mitochondrial reactive oxygen species (mtROS). The expressions of protein JunB, Fra-1 and Matrix metalloproteinase 2 (MMP) evidently increased after C. pneumoniae infection, and the interaction between JunB and Fra-1 was also enhanced. After scavenging mtROS by antioxidant Mito-TEMPO, the increasing expressions of JunB, Fra-1, MMP2 and the capacity of VSMC migration induced by C. pneumoniae infection were all inhibited. In comparison with infected ApoE mice, the level of ROS in atherosclerotic lesion in ApoETLR2 mice with C. pneumoniae infection decreased. Knocking out TLR2 suppressed the expressions of JunB, Fra-1 and MMP2 in VSMCs and the formation of atherosclerotic lesion after C. pneumoniae infection. Furthermore, after using small interfering RNA to inhibit the expression of TLR2, the level of mtROS and the expressions of JunB, Fra-1 and MMP2 apparently decreased. Taken together, C. pneumoniae infection may promote VSMC migration and atherosclerosis development by increasing the level of mtROS through TLR2 to activate the JunB-Fra-1/MMP2 signaling pathway. The data provide the first evidence that antioxidant could reduce C. pneumoniae infection-induced VSMC migration and atherosclerosis.

使用產品

在該研究過程中，科研團隊研究人員使用了HAKATA的產品：

HAKATA PBS 緩沖液   （貨號:A19711）

能夠為該研究提供助力，蒂科生物/HAKATA深感榮幸。

以下圖片來自文獻：

如果您也使用HAKATA系列產品發表的文章已被sci收錄 ，請致電我們，詳見“你發文，我有獎"活動。